Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity Featured Duab

Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API Siab Purity

Lus piav qhia luv luv:

Lub npe tshuaj: Lasofoxifene Tartrate

CAS: 190791-29-8 Nr

Cov tsos mob: Dawb rau Off-White hmoov

Chiral Purity: ≥99.0%Purity: ≥98.0% (HPLC)

Hauv kev kho mob Postmenopausal Osteoporosis

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Xa email rau peb

Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chaw tsim tshuaj paus Supply nrog High Purity thiab ruaj khov zoo
Lub npe tshuaj: Lasofoxifene Tartrate
CAS: 190791-29-8 Nr
Lasofoxifene Tartrate (CAS: 190791-29-8) hauv kev kho mob Postmenopausal Osteoporosis

Chemical Properties:

Tshuaj npe	Lasofoxifene Tartrate
Synonyms	(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol Tartrate Oporia
CAS Nr	190791-29-8
CAT Number	RF-API 20
Tshuag xwm txheej	Nyob rau hauv Tshuag, ntau lawm Scale nce mus txog pua pua ntawm Kilograms
Molecular Formula	C28H31NO2.ClH
Molecular Luj	450.019 Nws
Hom	Ruifu Tshuaj

Specifications:

Yam khoom	Specifications
Qhov tshwm sim	Dawb rau Off-White Powder
Moisture (KF)	≤0.50%
Hnyav Hlau	≤ 20ppm
Chiral Purity	≥99.0%
Purity / Analysis Method	≥98.0% (HPLC)
Poob rau ziab	≤0.50%
Residue ntawm Ignition	≤0.50%
Test Standard	Suav Pharmacopoeia (CP);Enterprise Standard
Kev siv	Cov khoom xyaw tshuaj nquag (API);Postmenopausal Osteoporosis

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.

Qhov zoo:

FAQ:

Daim ntawv thov:

Shanghai Ruifu Chemical Co., Ltd. yog cov chaw tsim khoom thiab cov chaw muag khoom ntawm Lasofoxifene Tartrate (CAS: 190791-29-8) nrog cov khoom zoo.
Lasofoxifene Tartrate yog ib tiam thib peb, uas tsis yog-steroidal xaiv estrogen receptor modulator (SERM).Nws xaiv khi rau tib neeg ERalpha nrog IC50 tus nqi ntawm 1.5 nM thiab inhibits pob txha poob hauv ovariectomized nas.Hauv kev tshawb fawb soj ntsuam ntawm postmenopausal osteoporosis, 0.5 mg / hnub lasofoxifene tau cuam tshuam nrog txo qis kev pheej hmoo ntawm cov pob txha tsis muaj pob txha thiab pob txha, ER-zoo mob qog noj ntshav, kab mob plawv, thiab mob hlab ntsha tawg tab sis muaj kev pheej hmoo ntawm cov kab mob venous thromboembolic.Lasofoxifene kuj tau pom tias ua tus agonist inverse ntawm CB2 cannabinoid receptor, qhia tias nws muaj peev xwm yuav tsum tau repurposed raws li ib tug kho mob rau indications wherein CB2 yog lub hom phiaj.